12:00 AM
Aug 06, 2007
 |  BC Week In Review  |  Clinical News  |  Clinical Status

Chronocort: Phase II start

This month, PQS will begin an open-label, U.S. Phase II trial (Study 004) in 130 patients to evaluate corticosteroids plus either...

Read the full 81 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >